Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 85519 · Class II · Mississippi Blood Services Inc.
Key facts
| Event ID | 85519 |
|---|---|
| Recall numbers | B-0452-2020, B-0453-2020, B-0454-2020, B-0455-2020 |
| Recalling firm | Mississippi Blood Services Inc. |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced, Apheresis Platelets, Leukocytes Reduced, Irradiated, Blood and Blood Products for Reprocessing, Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. |
| Initiation date | Mar 11, 2020 |
| Report date | May 6, 2020 |
| Termination date | Apr 24, 2020 |
| City | Flowood |
| State | MS |
| Country | United States |
| FEI number | 1048744 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: